Piper Jaffray Starts Avanir Pharmaceuticals (AVNR) at Overweight
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 31 | Down: 44 | New: 4
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 31 | Down: 44 | New: 4
Join SI Premium – FREE
Piper Jaffray initiates coverage on Avanir Pharmaceuticals (NASDAQ: AVNR) with a Overweight. PT $6.00.
For an analyst ratings summary and ratings history on Avanir Pharmaceuticals click here. For more ratings news on Avanir Pharmaceuticals click here.
Shares of Avanir Pharmaceuticals closed at $2.81 yesterday.
For an analyst ratings summary and ratings history on Avanir Pharmaceuticals click here. For more ratings news on Avanir Pharmaceuticals click here.
Shares of Avanir Pharmaceuticals closed at $2.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Shanghai V-Test Semiconductor (688372:CH) at Overweight
- Evercore ISI Resumes ESAB (ESAB) at In Line
- H.C. Wainwright Starts Atrium Therapeutics (RNA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
